Autotransfusion Devices Market Growth, Size & Industry Forecast - 2027


The growth of the market is driven by factors such as the involvement of rare blood groups, rising number of transplant procedures, and rising prevalence of chronic diseases in the North America region. Whereas, risks associated with autotransfusion is likely to have a negative impact on the growth of the market in the coming years.

The autotransfusion process involves the reinfusion of the patient's blood. Blood is collected from the peritoneal cavity or thorax region. The process can be carried out before surgery or during and after the surgery using the autotransfusion system. Medical procedures, like joint replacement, spinal surgeries, and cardiac, among others, require autotransfusion. It helps to reduce the risk of infection, and also it eliminates the problems and complications associated with the banking and administration of homologous donor blood. It helps to prevent the transmission of transfusion-related blood-borne diseases in patients.


Key Players Influencing the Market:
  1. BD
  2. Braile Biomedica
  3. Fresenius SE & Co. KGaA
  4. Haemonetics Corporation
  5. LivaNova PLC
  6. Medtronic
  7. Redax S.p.A.
  8. SARSTEDT AG and Co. KG
  9. Teleflex Incorporated
  10. Zimmer Biomet.

The autotransfusion systems are widely used in various surgical procedures such as cardiac surgery, trauma procedures, orthopedic procedures, and other invasive procedures. These procedures are followed by excessive blood loss, and it is difficult to obtain blood of rare group in emergency cases. Autotransfusion system facilitates to reinfuse the patient’s blood back into the body after the due filtration process.

For instance, in the US blood group AB positive is among the rarely found blood group about 196.94 million (0.6%) of the population in 2019 in such cases of rare blood group is difficult to arrange in case if urgent equipment during surgical procedures. Thus, the autotransfusion system is one of the procedures useful for patients with rare blood groups, where the patient’s blood is reinfused in the body. This can be done efficiently with use of appropriate type of autotransfusion devices. Owing to these facts, the cases of involvement of rare blood group are likely to boost the market in the coming years.

The need for reinfusion of blood and robust advancements in healthcare facilities and infrastructure in North America is expected to drive the growing in the country create a lucrative opportunity and the presence of an established market for autotransfusion devices.

Purchase for Report @ https://bit.ly/3avARp0

Key Benefits:
  • This report provides a detailed study of market trends and forecast from 2019 to 2025, which assist to identify the prevailing market opportunities.
  • In-depth coverage of the global market that includes drivers, restraints, and opportunities, helps professionals to understand the market behavior in a better way.
  • Detailed study of the strategies of key leaders, partnerships, and acquisitions in the market is provided.


Comments

Popular posts from this blog

Immunochemistry Equipment Market to Reflect a Holistic Expansion During 2019 to 2027

Biopharmaceutical Contract Manufacturing Market to Witness an Outstanding Growth by 2027

Patient Registry Software Market Set for Rapid Growth and Trend by 2027